Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
McKesson
QuintilesIMS
Merck
Baxter

Generated: June 19, 2019

DrugPatentWatch Database Preview

FOUGERA PHARMS Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and what generic alternatives to FOUGERA PHARMS drugs are available?

FOUGERA PHARMS has one hundred and thirteen approved drugs.

There are four US patents protecting FOUGERA PHARMS drugs.

There are fifty-nine patent family members on FOUGERA PHARMS drugs in twenty-seven countries and forty-four supplementary protection certificates in fifteen countries.

Summary for FOUGERA PHARMS
International Patents:59
US Patents:4
Tradenames:54
Ingredients:46
NDAs:113

Drugs and US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 085691-001 Approved Prior to Jan 1, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 085691-003 Approved Prior to Jan 1, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc NYSTATIN nystatin SUSPENSION;ORAL 062517-001 Jun 7, 1984 AA RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms DIFLORASONE DIACETATE diflorasone diacetate CREAM;TOPICAL 076263-001 Dec 20, 2002 BX RX No Yes ➤ Sign Up ➤ Sign Up
Fougera Pharms MUPIROCIN mupirocin OINTMENT;TOPICAL 065192-001 Nov 30, 2005 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 085691-002 Approved Prior to Jan 1, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019141-001 Sep 4, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 3,721,687 ➤ Sign Up
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 5,968,973 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,792,753 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,852,002 ➤ Sign Up
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,639,738 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,985,850 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28

Supplementary Protection Certificates for FOUGERA PHARMS Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1458369 08C0024 France ➤ Sign Up PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
1304992 122013000081 Germany ➤ Sign Up PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
2506844 2018C/022 Belgium ➤ Sign Up PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117
0842660 C300581 Netherlands ➤ Sign Up PRODUCT NAME: DROOG EXTRACT VAN GROENE THEE; NAT. REGISTRATION NO/DATE: RVG 110904 20120917; FIRST REGISTRATION: 73486.00.00 20090831
1304992 SPC/GB13/061 United Kingdom ➤ Sign Up PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992 2013C/060 Belgium ➤ Sign Up PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1458369 SPC/GB10/005 United Kingdom ➤ Sign Up PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
McKinsey
Merck
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.